QUANTITATIVE ASSESSMENT OF EPIDERMAL MELANOGENESIS IN C3H/TIF HR/HR MICE TREATED WITH TOPICAL FUROCOUMARINS AND UVA RADIATION

被引:18
作者
KINLEY, JS
MOAN, J
DALLAQUA, F
YOUNG, AR
机构
[1] NORWEGIAN RADIUM HOSP,INST CANC RES,DEPT BIOPHYS,N-0310 OSLO,NORWAY
[2] UNIV PADUA,FAC PHARM,PADUA,ITALY
关键词
UVA; FUROCUMARIN; PSORALEN; TRIMETHYLANGELICIN; 8-MOP; 5-MOP; 5-GOP; BERGAMOTTIN; KHELLIN; MELANOGENESIS; PHOTOSENSITIZATION;
D O I
10.1111/1523-1747.ep12391828
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
We report quantitative data on epidermal melanogenesis by established and new furocoumarins. The ears and dorsal skin of pigmented hairless mice were treated for 12 d with compounds in ethanol, at equi-optical concentrations, and exposed to subphototoxic doses of ultraviolet A. Increased pigmentation was observed with 6,4,4'-trimethylangelicin > psoralen > 8-methoxypsoralen > 5-methoxypsoralen > 4,4', 5'-trimethylazapsoralen = bergamot oil. Assessment of melanocyte numbers and morphology in epidermal sheet dihydroxyphenylalanine preparations showed that 6,4,4'-trimethylangelicin was the best compound with 536 ear melanocytes/mm(2) +/- 15 SEM compared with 46 +/- 4 in controls. Psoralen induced 297/mm(2) +/- 33, compared with its methoxy derivatives with ranges between 200 and 240/mm(2). 6,4,4'-trimethylangelicin had a striking effect on dorsal skin with 462 +/- 18 melanocytes/mm(2) compared to less than 80/mm(2) in all other ultraviolet A treatment groups. Khellin, 5-GOP and ultraviolet A only and all non-ultraviolet A controls had no effect. Melanogenesis was associated with increased dendricity, melanocyte size, especially with 5-methoxypsoralen, and giant melanocytes were noted with some treatments. The potency of 6,4,4' -trimethylangelicin, which does not form DNA interstrand crosslinks, may be related to its high DNA binding constant. Our data may be useful in the selection of compounds to treat vitiligo.
引用
收藏
页码:97 / 103
页数:7
相关论文
共 45 条
[11]   ROLE OF HAIR-FOLLICLES IN THE REPIGMENTATION OF VITILIGO [J].
CUI, J ;
SHEN, LY ;
WANG, GC .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1991, 97 (03) :410-416
[12]  
DALL'ACQUA F, 1985, Drugs of the Future, V10, P307
[13]   PHOTOCHEMOTHERAPY USING PYRIDOPSORALENS [J].
DUBERTRET, L ;
AVERBECK, D ;
BISAGNI, E ;
MORON, J ;
MOUSTACCHI, E ;
BILLARDON, C ;
PAPADOPOULO, D ;
NOCENTINI, S ;
VIGNY, P ;
BLAIS, J ;
BENSASSON, RV ;
RONFARDHARET, JC ;
LAND, EJ ;
ZAJDELA, F ;
LATARJET, R .
BIOCHIMIE, 1985, 67 (3-4) :417-422
[14]  
GASPARRO FP, 1988, PSORALEN DNA PHOTOBI, V1, P5
[15]   6-METHYLANGELICINS - A NEW SERIES OF POTENTIAL PHOTOCHEMOTHERAPEUTIC AGENTS FOR THE TREATMENT OF PSORIASIS [J].
GUIOTTO, A ;
RODIGHIERO, P ;
MANZINI, P ;
PASTORINI, G ;
BORDIN, F ;
BACCICHETTI, F ;
CARLASSARE, F ;
VEDALDI, D ;
DALLACQUA, F ;
TAMARO, M ;
RECCHIA, G ;
CRISTOFOLINI, M .
JOURNAL OF MEDICINAL CHEMISTRY, 1984, 27 (08) :959-967
[16]   PSORALEN-UVA-TREATED PSORIATIC LESIONS - ULTRASTRUCTURAL CHANGES [J].
HASHIMOTO, K ;
KOHDA, H ;
KUMAKIRI, M ;
BLENDER, SL ;
WILLIS, I .
ARCHIVES OF DERMATOLOGY, 1978, 114 (05) :711-722
[17]  
HO KKL, 1992, MELANOMA RES, V2, P41
[19]   MELANIN REDUCES ULTRAVIOLET-INDUCED DNA-DAMAGE FORMATION AND KILLING RATE IN CULTURED HUMAN-MELANOMA CELLS [J].
KOBAYASHI, N ;
MURAMATSU, T ;
YAMASHINA, Y ;
SHIRAI, T ;
OHNISHI, T ;
MORI, T .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1993, 101 (05) :685-689
[20]   SYSTEMIC SUPPRESSION OF CONTACT HYPERSENSITIVITY IN MICE BY PSORALEN PLUS UVA RADIATION (PUVA) [J].
KRIPKE, ML ;
MORISON, WL ;
PARRISH, JA .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1983, 81 (02) :87-92